Viking Thera
(VKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -201,977 | -111,190 | -45,629 | -109,963 | -74,546 |
| Depreciation Amortization | -7,160 | -5,253 | -2,998 | -16,827 | -12,930 |
| Accounts payable and accrued liabilities | -5,400 | -4,319 | -2,110 | 2,303 | -7,258 |
| Other Working Capital | -16,501 | -7,858 | -15,062 | 9,362 | 6,906 |
| Other Operating Activity | 37,643 | 29,228 | 13,468 | 27,335 | 31,219 |
| Operating Cash Flow | $-193,395 | $-99,392 | $-52,331 | $-87,790 | $-56,609 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 265,776 | 105,751 | 63,245 | -553,366 | -559,950 |
| Investing Cash Flow | $265,776 | $105,751 | $63,245 | $-553,366 | $-559,950 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,336 | 856 | 349 | 10,813 | 9,813 |
| Other Financing Activity | 0 | 0 | 0 | 601,651 | 601,651 |
| Financing Cash Flow | $1,336 | $856 | $349 | $612,464 | $611,464 |
| Exchange Rate Effect | -17 | -11 | 1 | -148 | -74 |
| Beginning Cash Position | 26,676 | 26,676 | 26,676 | 55,516 | 55,516 |
| End Cash Position | 100,376 | 33,880 | 37,940 | 26,676 | 50,347 |
| Net Cash Flow | $73,700 | $7,204 | $11,264 | $-28,840 | $-5,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -193,395 | -99,392 | -52,331 | -87,790 | -56,609 |
| Free Cash Flow | -193,395 | -99,392 | -52,331 | -87,790 | -56,609 |